Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / IL-37 alleviates intervertebral disc degeneration via the IL-1R8/NF-κB pathway.

< BACK TO ARCHIVE


Papers: 21 Jan 2023 - 3 Feb 2023


2023 Jan 21


Osteoarthritis Cartilage


http://www.ncbi.nlm.nih.gov/pubmed/36693558?dopt=Abstract

IL-37 alleviates intervertebral disc degeneration via the IL-1R8/NF-κB pathway.

Authors

IL-37 alleviates intervertebral disc degeneration via the IL-1R8/NF-κB pathway.
Li S, Pan X, Wu Y, Tu Y, Hong W, Ren J, Miao J, Wang T, Xia W, Lu J, Chen J, Hu X, Lin Y, Zhang X, Wang X
Osteoarthritis Cartilage. 2023 Jan 21.
PMID: 36693558.

Abstract

Intervertebral disc degeneration (IDD) has been reported to be a major cause of low back pain. Interleukin (IL)-37 is an anti-inflammatory cytokine of the interleukin-1 family, which exerts salutary physiological effects. In this study, we assessed the protective effect of IL-37 on IDD progression and its underlying mechanisms.
Read This Paper